|
|
Volumn 71, Issue 6, 2014, Pages 446-447
|
|
Stakeholders discuss biosimilar naming, substitution
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOSIMILAR AGENT;
COMPETITION;
DRUG COST;
DRUG NOMENCLATURE;
DRUG SUBSTITUTION;
DRUG SURVEILLANCE PROGRAM;
HUMAN;
LAW;
NOTE;
PATIENT SAFETY;
PHARMACIST;
PRESCRIPTION;
CLASSIFICATION;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
GOVERNMENT;
LEGAL ASPECT;
METHODOLOGY;
STANDARD;
UNITED STATES;
BIOSIMILAR PHARMACEUTICALS;
DRUG APPROVAL;
DRUG SUBSTITUTION;
HUMANS;
UNITED STATES;
UNITED STATES FEDERAL TRADE COMMISSION;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84907198980
PISSN: 10792082
EISSN: 15352900
Source Type: Journal
DOI: 10.2146/news140023 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
